Population impact of different hypertension management guidelines based on the prospective population-based Heinz

Janine Gronewold1, Rene Kropp2, Nils Lehmann3

  • 1Department of Neurology, University Hospital Essen, Essen, Germany janine.gronewold@uk-essen.de.

BMJ Open
|February 18, 2021
PubMed

Insights

The ACC/AHA 2017 hypertension guideline recommends medication for more people, who then show higher cardiovascular event rates. Further trials are needed to confirm if this stricter guideline reduces cardiovascular disease.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Hypertension guidelines vary significantly across different societies.
  • The ACC/AHA 2017 guideline recommends antihypertensive medication for a larger population segment compared to previous guidelines.
  • The comparative impact of different hypertension guidelines on cardiovascular risk has not been systematically evaluated.

Purpose of the Study:

  • To compare the prevalence of antihypertensive medication recommendations across major international hypertension guidelines.
  • To assess the association between guideline-based medication recommendations and incident cardiovascular events.

Main Methods:

  • The Heinz Nixdorf Recall study population (n=3092) without baseline medication was analyzed.
  • Prevalence of medication recommendation was compared using ACC/AHA 2017, JNC7, ESH/ESC 2013/2018, and WHO/ISH 2003/2020 guidelines.
  • Incident cardiovascular events were compared between participants with and without medication recommendations over a 5-year follow-up.

Main Results:

  • The ACC/AHA 2017 guideline identified the highest proportion of individuals (45.8%) for medication.
  • Compared to other guidelines, ACC/AHA 2017 recommended medication for significantly more participants.
  • Participants recommended for medication by ACC/AHA 2017 had a higher 5-year incidence of cardiovascular events (2.5% vs 1.1%, p=0.003).

Conclusions:

  • The ACC/AHA 2017 guideline identifies a higher-risk population for antihypertensive medication.
  • A higher incidence of cardiovascular events was observed in those recommended for medication under the ACC/AHA 2017 guideline.
  • Randomized controlled trials are warranted to determine if implementing the ACC/AHA 2017 guideline reduces cardiovascular disease.
Abstract

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
157
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
191
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
282
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
326
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.1K